| Company | Market cap | P/E | Revenue | Rev. growth | Net income | Cash | Debt | AI value |
|---|---|---|---|---|---|---|---|---|
| JBIJanus International Group, Inc. | $697.19M | 21.3× | $884.2M | -8.3% | $53.8M | $127M | $545M | AI pending |
| MLABMesa Laboratories Inc | $698.14M | 147.6× | $249.13M | +3.4% | $6.71M | $30.7M | $66.09M | AI pending |
| BAKBraskem Sa | $699.86M | — | R$77.41B | +9.7% | -R$11.32B | R$14.99B | R$65.23B | AI pending |
| ASMBAssembly Biosciences, Inc. | $700M | — | $72.3M | +153.5% | -$6.12M | $32.29M | $419.38K | AI pending |
| PFISPeoples Financial Services Corp. | $702.13M | 12.4× | $187.69M | +39.7% | $59.19M | $256.25M | $85.33M | AI pending |
| CWBCCommunity West Bancshares | $703.24M | 14.0× | $146.67M | +25.6% | $38.17M | $206.84M | $69.53M | AI pending |
| ZVRAZevra Therapeutics, Inc. | $704.89M | 12.8× | $106.47M | +350.9% | $83.23M | $145.32M | $0 | AI pending |
| GDRZFGold Reserve Ltd | $707.03M | — | — | — | — | $54.61M | — | AI pending |
| CCBCoastal Financial Corp | $707.37M | — | $541.67M | -6.8% | $46.99M | $1.01B | — | AI pending |
| RGNXREGENXBIO Inc. | $707.66M | — | $170.44M | +104.5% | -$193.88M | $36.49M | — | AI pending |
| IRWDIronwood Pharmaceuticals Inc | $708.88M | 5.6× | $296.15M | -15.7% | $24.02M | $79.13M | $199.51M | AI pending |
| MTWManitowoc Co Inc | $709.7M | 35.8× | $2.24B | +2.9% | $7.2M | $95.8M | $460.6M | AI pending |
| CCSIConsensus Cloud Solutions, Inc. | $710.46M | 7.9× | $349.7M | -0.2% | $84.53M | $98.9M | $555.29M | AI pending |
| AROWArrow Financial Corp | $712.79M | 12.4× | $133.95M | -10.2% | $30.08M | $186.79M | $310.19M | AI pending |
| NMFCNew Mountain Finance Corp | $714.06M | — | $327.08M | -12.0% | $16.49M | $64.8M | $1.35B | AI pending |
| CTMXCytomX Therapeutics, Inc. | $714.71M | — | $76.2M | -44.8% | -$17.37M | $17.22M | $2.99M | AI pending |
| REEMFRare Element Resources Ltd | $715.71M | — | $0 | — | -$4.9M | $26.81M | $1M | AI pending |
| SUPVGrupo Supervielle S.A. | $717.19M | — | ARS 857.59B | -13.9% | ARS 104.49B | ARS 652.98B | — | AI pending |
| PHATPhathom Pharmaceuticals, Inc. | $717.59M | — | $175.11M | +216.9% | -$221.25M | $182.48M | $164.59M | AI pending |
| SSIISS Innovations International, Inc. | $718.38M | — | $42.48M | +105.7% | -$12.13M | $13.65M | $510.19K | AI pending |